Delivery Order SPE2DB22D3016-SPE2DB25FBJJ3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen auto-injectors, with a ceiling value of $1,904.63 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 7, 2025, with performance executed from the company's headquarters in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing...
- The Defense Logistics Agency awarded a $34,843.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injectors. The contract, which is a child order under a larger indefinite delivery vehicle, has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,613.98 on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of September 8, 2025. The product will be performed and sourced from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,044.24 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors (0.5 ml). The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The contract specifies a completion date of July 31, 2025, and lists the place of performance as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,904.63 on August 9, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a ceiling value of $1,578.87. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a ceiling value of $10,125.09. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $13,618.11 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectors on September 12, 2025, with a completion date of September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections with a firm fixed price ceiling value of $1,088.36. This competitively awarded, non-set-aside contract is classified as a delivery order with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJJ3Delivery Order
The Defense Logistics Agency awarded a $5,450.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen auto-injectors. This delivery order, which is a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA, carries an ultimate completion date of September 16, 2025. The award was competitively procured with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a comprehensive $999.999 billion indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) through December 2026, which serves as the overarching vehicle for this delivery order. This prime contract enables AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines, to support military healthcare programs globally. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive medical procurement requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 9/15/25 |